Comparative analysis of first versus latest version of WHO essential medicine list

Abstract

Background The concept of Essential medicines was pioneered by the WHO in 1977 to provide safe and effective treatment against the global burden of disease. Latest, 19thEML by WHO and 4th list of NLEM are published in 2015 Aims and Objectives To study the factors affecting the change in profile of Essential medicine list. Materials and Methods The EML was accessed from the official website of WHO and the NLEM from Central Drugs Standard Control Organization website, downloaded and compared. A detailed analysis of 1st and latest EML was done in terms of System wise allocation, addition and deletion of medicines Results There is steady increase in number of Essential Medicines from 204 to 414 in latest EML of WHO when compared to first list. Maximum allocation of medicines in WHO first list is for Infectious disease (53/204,26%) followed by Cardiovascular diseases (25/204,12%),Central nervous system disorders (15/204,7%) whereas in latest version of EML by WHO maximum allocation of medicines is to Infectious diseases (135/414,33%) followed by antineoplastic medicines (47/414,11%), cardiovascular disorders (32/414,8%). Maximum increase in medicines is seen with following sub categories of diseases like Antineoplastic (47), Anti viral drugs (27), Anti tubercular drugs (17), Contraceptives (16), antidotes (15). Some of the medicines like Atorvastatin, Telmisartan, Glimepiride, Thiopentone, cetirizine etc are included in NLEM 2015 but not included in WHO-EML 2015 Conclusion The study gives insight about the change in profile of medicines in essential medicine list over a period of time with respect to change in burden of disease, newer diseases , newer invention of safe and effective medicines

Authors and Affiliations

Kavyashree AC

Keywords

Related Articles

Study on Rational Use of Anti-Diabetic Drugs in Patients with Diabetes and Other Co-Morbidities

India presently has the largest number of diabetic patients in world and has been infamously dubbed as the ‘Diabetic capital of the world’. The study was undertaken to know the prevalence of Diabetic population and to e...

Effect of verapamil and nimodipine in reversing the ethanol withdrawal induced anxiety in rats

BACKGROUND AND OBJECTIVE Anxiety that occurs during alcohol withdrawal may be the precipitating factor for relapse of alcoholism. Earlier studies have demonstrated calcium channel activity peaks during alcohol withdrawa...

Introducing an evidence based medicine course to second year medical students - evaluating its effectiveness and student feedback

Objectives: To study the effectiveness of Introducing an Evidence Based Medicine (EBM) course in the curriculum of Second Year Medical Students and to obtain their feedback regarding the same. Methods: 66 students conse...

A cross sectional study of hair dye use among doctors and nurses working at a tertiary care centre

Background Hair dye products are being extensively used worldwide to enhance an individual outlook. More than two thirds of hair dyes currently contain PPD (paraphenelenediamine) which is a potent allergen and also a ca...

A new looming of Middle East respiratory syndrome coronavirus MERSCoV

Middle East Respiratory Syndrome Coronavirus is the species of genus Beta Coronavirus. A novel human coronaviruses are single-stranded RNA. They are distinct from SARS and common cold viruses. First case of MERS-CoV was...

Download PDF file
  • EP ID EP412943
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Kavyashree AC (2017). Comparative analysis of first versus latest version of WHO essential medicine list. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 6(2), 224-231. https://europub.co.uk/articles/-A-412943